Envista (NVST)
(Delayed Data from NYSE)
$16.50 USD
+1.20 (7.84%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $16.52 +0.02 (0.12%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 36% (90 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.85 | 1.69 | 9.99 |
Current Quarter Estimate | 0.27 | 5.88 | 61.00 |
Year Ago Quarter Estimate | 0.43 | 4.88 | 54.84 |
Next Quarter Estimate | 0.29 | 7.06 | 63.00 |
Next Year Estimate | 1.25 | 39.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -24.84 | 15.40 | 15.67 |
Next Year | 8.70 | 26.00 | 11.34 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | 1.00 | 15.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.14 | -13.85 |
Price/Book (MRQ) | 0.95 | 2.10 |
Price/Cash Flow (MRFY) | 6.48 | 11.31 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -52.25% | -1.09% |
Return on Equity (TTM) | 4.86% | 10.15% |
Debt to Equity (MRQ) | 0.47 | 33.03 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.